Abstract | AIM: METHODS: We systematically searched MEDLINE, EMBASE, and the Cochrane Library (search date: 8 January, 2019). Studies on patients who experienced return of spontaneous circulation, who had out of hospital cardiac arrest and had their level of procalcitonin measured and outcomes assessed at and after hospital discharge, were included. We additionally performed subgroup analyses for confounding factors affecting patients' outcomes. To assess the risk of bias of each included study, the Quality in Prognosis Studies tool was used. RESULTS: A total of 1065 patients from 10 studies were finally included. Elevated procalcitonin level during hospital admission (at 0-24 h) was associated with in-hospital mortality (standardized mean difference (SMD) 0.64, 95% confidence interval (CI) 0.33-0.95, I2 = 26%). The elevation of procalcitonin level (at 0-48 h) was also associated with poor neurologic outcomes (at 0-24 h, SMD 0.61; 95% CI 0.44-0.79, I2 = 0%; at 24-48 h, SMD 0.58, 95% CI 0.35-0.82, I2 = 0%) as well as at 1-6 months (at 24-48 h, SMD 0.62; 95% CI 0.36-0.88, I2 = 0%). CONCLUSIONS:
|
Authors | Hyungoo Shin, Jae Guk Kim, Wonhee Kim, Tae Ho Lim, Bo-Hyoung Jang, Youngsuk Cho, Kyu-Sun Choi, Chiwon Ahn, Juncheol Lee, Min Kyun Na |
Journal | Resuscitation
(Resuscitation)
Vol. 138
Pg. 160-167
(05 2019)
ISSN: 1873-1570 [Electronic] Ireland |
PMID | 30872069
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Copyright | Copyright © 2019 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Biomarkers
(blood)
- Cardiopulmonary Resuscitation
(methods)
- Global Health
- Hospital Mortality
(trends)
- Humans
- Out-of-Hospital Cardiac Arrest
(blood, mortality)
- Procalcitonin
(blood)
- Prognosis
- Survival Rate
(trends)
|